SpyGlass Pharma, Inc.
SGPSurgical & Medical Instruments & Apparatus · SIC 3841 · CIK 0001778922
Revenue FY2025
—
Net Income
$(40.0M)
EPS (Basic)
$-17.98
Net Margin
—
ROE
40.3%
Total Equity
$(99.0M)
Shares Out
33M
SpyGlass Pharma, Inc. — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2024–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 3 funds in our universe
Insider Transactions
Reading stored insider transactions…